Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Jul 2025 for Blueprint Medicines Corp. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Habib J. Dable: trading record in brief
Filings by Habib J. Dable span 2 companies, the busiest being Blueprint Medicines Corp and Acceleron Pharma Inc. The record holds 7 filings, for trades running from 1 July 2021 to 17 July 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 21 July 2025 came the latest disclosure, a transaction in Blueprint Medicines Corp. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Habib J. Dable
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
3,902 sharesCommon StockSEC:0001104659-25-069395:0
3,902 shares@ US$128.12100.0% of flowCommon StockSEC:0001415889-25-018073:0
2,242 shares0Common StockSEC:0001415889-24-016979:0
2,600 shares0Common StockSEC:0001415889-23-010260:0
3,900 shares0Common StockSEC:0001415889-22-006974:0
98,450 sharesCommon StockSEC:0001104659-21-142265:0
57,814 shares@ US$35.04100.0% of flowCommon StockSEC:0001179110-21-007353:0
7 of 7 declarations
